TXNIP and diabetes mellitus: Glucose-induced TXNIP expression in diabetes has also been observed in non-beta cells—like in primary human aortic endothelial cells in a T1D-like rat model [63] and in the skeletal muscle of prediabetic and diabetic patients [60]—confirming its contribution in glucose-induced secondary complications of diabetes.